| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |